Gaetan Duport: The Next Challenge for Patient Involvement at EMA
Gaetan Duport, User Representative on the Economic and Public Health Committee (CEESP) at French National Authority for Health, shared on LinkedIn:
”EMA’s 2024–2025 stakeholder report is worth reading closely from a patient involvement perspective.
Patient participation at EMA is becoming more embedded in procedure, not just consultation.
The Agency revised its CHMP public assessment report template to reflect patient input and patient experience data, introduced a form to capture patient input in scientific advice, and expanded the PCWP from 22 to 25 organisations.
But the report also confirms something patient organisations know very well: meaningful participation is resource-intensive.
In 2024, 70 patients and carers contributed to 67 procedures; in 2025, 53 contributed to 53.
By December 2025, EMA had 42 eligible patient and consumer organisations.
That is real influence — but it also points to a small, highly mobilised ecosystem carrying a heavy operational load.
This is why the 2025 mobilisation on voting rights mattered.
More than 70 additional patient organisations joined EPF and EURORDIS in calling for meaningful patient involvement and retention of voting rights.
EMA’s Management Board minutes later noted with satisfaction that patient priorities, including voting rights, had been included — while also warning that participation depends on a very small pool of people and requires adequate support.
The real issue in 2026 is no longer only recognition in principle.
It is follow-up: capacity, continuity, support, and the ability of patient organisations to remain present where decisions are actually shaped and budget cut.
The General Pharmaceutical Legislation is expected to come into late 2026, followed by a Lon transition period.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers